NAT10 and neoplasm: In melanoma, NAT10 silencing induces S-phase cell cycle arrest by downregulating Microphthalmia-associated Transcription Factor (MITF) expression, significantly suppressing tumor cell proliferation in both in vitro and in vivo experimental systems (Oh et al., 2017).